TheProfitWatch

QNCX - Quince Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.9 0.1 (5.26%) --- 0.0 (0.0%) 0.05 (2.56%) 0.0 (0.0%) 0.02 (0.77%) 0.05 (2.56%) 0.05 (2.56%)

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.34
Diluted EPS:
-0.34
Basic P/E:
-5.8824
Diluted P/E:
-5.8824
RSI(14) 1m:
100.0
VWAP:
1.99
RVol:

Events

Period Kind Movement Occurred At

Related News